Gastric point‐of‐care ultrasound in the GLP‐1 receptor agonist era: clinical impact and competency

Documenti analoghi

• Gastric ultrasound and mitigating risk of glucagon‐like peptide‐1 receptor agonists: a reply
  di: Peter C.‐A. Kam, et al.
  Pubblicazione: (2024)
• Considerations on peri‐operative management of GLP ‐1 receptor agonists
  di: Glenio B. Mizubuti, et al.
  Pubblicazione: (2024)
• The fasting and the furious: reconciling fasting guidelines with glucagon‐like peptide‐1 receptor agonists, ‘Sip‐til‐Send’ policies and gastric ultrasound
  di: N. S. Sidhu, et al.
  Pubblicazione: (2025)
• The controversy of pre‐operative opioid tapering and an opportunity to advance personalised, patient‐centred pain medicine
  di: Dáire N. Kelly, et al.
  Pubblicazione: (2024)
• Correction to: Glucagon‐like peptide‐1 receptor agonists: a narrative review of clinical pharmacology and implications for peri‐operative practice
  Pubblicazione: (2024)